GlassScriptPhysician profile
Juan E Sardina
NPI 1306099304
$21,305.80
in general payments reported to CMS, 2019-2025
39 companies · $7,439 in 2025
The $7,439 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,941 · 2020: $517 · 2021: $1,556 · 2022: $2,786 · 2023: $3,215 · 2024: $1,852 · 2025: $7,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,905 · Consulting Fee: $3,550 · Travel and Lodging: $2,881 · Long Term Medical Supply Or Device Loan: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,905.01 |
| Consulting Fee | $3,550.00 |
| Travel and Lodging | $2,880.56 |
| Long Term Medical Supply Or Device Loan | $170.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $4,601.29 | 2023-2025 | Biobrace 23mm, Colink 2, Colink Plating System |
| Stryker Corporation | $2,811.41 | 2019-2025 | Inbone, Augment Injectable, Vitoss |
| Orthofix Medical, INC. | $1,766.85 | 2020-2025 | Truelok, Physio-Stim |
| Integra Lifesciences Corporation | $1,744.87 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $1,546.96 | 2019-2025 | Grafix Pl, Evos, Oasis |
| Arthrex, INC. | $1,458.08 | 2022 | |
| Fusion Orthopedics USA, LLC | $1,223.05 | 2024-2025 | Polylock |
| Wright Medical Technology, INC. | $1,030.82 | 2019 | |
| Organogenesis INC. | $587.05 | 2019-2024 | Puraply, Apligraf |
| Flower Orthopedics Coporation | $558.61 | 2019-2021 | |
| Depuy Synthes Sales INC. | $523.01 | 2019-2023 | Na |
| Treace Medical Concepts, INC. | $462.82 | 2022-2025 | |
| Djo, LLC | $423.75 | 2019-2023 | Cmf |
| Biocomposites INC | $347.69 | 2022-2025 | Stimulan |
| Acera Surgical, INC. | $238.89 | 2023-2025 | Restrata Wound Matrix |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $220.35 | 2025 | |
| Kerecis Limited | $169.51 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Polynovo North America LLC | $156.23 | 2025 | Novosorb Btm |
| Embody, INC. | $154.71 | 2022 | |
| Terumo Bct, INC. | $148.85 | 2022 | |
| Relievant Medsystems, INC. | $140.77 | 2023 | Intracept |
| Lifenet Health | $124.46 | 2024 | Theragenesis Wound Matrix |
| Globus Medical, INC. | $123.02 | 2024-2025 | Allocate, Harvest |
| Pacira Pharmaceuticals Incorporated | $118.90 | 2021 | |
| Ossdsign USA Incorporated | $87.43 | 2024 | |
| Urgo Medical North America, LLC | $84.62 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Zimmer Biomet Holdings, INC. | $75.27 | 2021 | |
| Prosidyan, INC | $64.87 | 2021 | |
| Ossio INC | $51.55 | 2023 | |
| Vericel Corporation | $38.02 | 2024-2025 | Maci |
| Heron Therapeutics, INC. | $33.24 | 2025 | Zynrelef |
| Crossroads Extremity Systems, LLC | $28.33 | 2021 | |
| Bioventus LLC | $28.31 | 2019 | |
| Solventum Corporation | $27.99 | 2025 | Prevena, V.A.C.Instill, V.A.C.Ulta |
| Horizon Therapeutics Plc | $27.39 | 2021 | |
| Abbott Laboratories | $23.94 | 2024 | Eterna |
| Sanara Medtech INC. | $18.35 | 2024 | Celleraterx |
| Paragon 28, INC. | $18.09 | 2023 | Monkey Rings |
| Convatec INC. | $16.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Sardina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.